The Annals Summaries of the Latest Medical Research!
home help contact us subscription past issues search current issue
QUICK SEARCH:   [advanced]


     


Published Online, 25 July 2006, www.theannals.com, DOI 10.1345/aph.1G259.
 The Annals of Pharmacotherapy: Vol. 40, No. 7, pp. 1327-1335. DOI 10.1345/aph.1G259
© 2006 Harvey Whitney Books Company.
This Article
Right arrow Résumé Freely available
Right arrow Extracto Freely available
Right arrow Full Text
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amabile, C. M
Right arrow Articles by Bowman, B. J
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amabile, C. M
Right arrow Articles by Bowman, B. J

PAIN MANAGEMENT

Overview of Oral Modified-Release Opioid Products for the Management of Chronic Pain

Celene M Amabile, PharmD BCPS

Clinical Coordinator/Residency Program Director, Gaston Memorial Hospital, Gastonia, NC

Bill J Bowman, BSPharm PhD

Assistant Professor of Pharmaceutical Sciences, Department of Pharmaceutical Sciences, College of Pharmacy—Glendale, Midwestern University, Glendale, AZ

Reprints: Dr. Amabile, Gaston Memorial Hospital, 2525 Court Dr., Gastonia, NC 28053-1747, fax 704/834-3030, amabilec{at}gmh.org

OBJECTIVE: To evaluate pharmaceutical and pharmacotherapeutic differences in oral opioid modified-release products used in the management of chronic pain.

DATA SOURCES: Searches of MEDLINE (1966-May 2006) and an extensive review of peer reviewed journals were conducted using the key search terms opioid, morphine, hydromorphone, and oxycodone. Supplemental information was gathered through the American Pain Society, and limited but relevant information was obtained from manufacturers' labeling.

STUDY SELECTION AND DATA EXTRACTION: All articles identified from the data sources were evaluated. Information deemed relevant was included for this review if it introduced new or well supported concepts or clarified clinical practice issues.

DATA SYNTHESIS: The recognition and treatment of pain has become a major focus of healthcare professionals. The Joint Commission on Accreditation of Healthcare Organizations mandates compliance with recommended standards, outcome measures, and other initiatives. A general review of pain management and pharmacokinetic parameters are included.

CONCLUSIONS: Oral modified-release products have enabled patients to better maintain pain control due to convenient dosing intervals and sustained blood concentrations. The differences between available oral modified-release products are half-life, cost, and formulation (excipients and drug-release properties).

Key Words: hydromorphone, morphine, opioid, oxycodone

Published Online, July 25, 2006. www.theannals.com, DOI 10.1345/aph.1G259

THIS ARTICLE IS APPROVED FOR CONTINUING EDUCATION CREDIT
ACPE UNIVERSAL PROGRAM NUMBER: 407-000-06-017-H01




homecopy help contact us subscription past issues search current issue
Copyright © 2006 by Harvey Whitney Books Company.